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Capstone Introduction: 
This document represents the culmination of my journey towards obtaining a 
Doctorate of Nursing Practice.  Here are three papers which I feel represent the 
enrichment that the doctoral process has provided; an quality improvement program 
evaluation, a literature review on an alternate vehicle for delivering therapy, and a paper 
addressing issues with end of life care in the critical care setting.   
Manuscript one is a retrospective evaluation of a bedside nurse-driven sepsis 
screening that was implemented at my place of employment.  This study evaluated the 
impact that the bedside screening process had on identifying the early development of 
sepsis, the initiation of sepsis treatment therapy, and if there was an impact on disease 
severity, mortality, and utilization of critical care facilities.     
Manuscript two is a review of the literature to address what I feel is a potential 
solution to an identified clinical issue that stemmed from manuscript one; that of a 
deficiency in the provision of sepsis treatment therapy.   In this manuscript I review if 
there is evidence in the literature that this specialized care could be better administered by 
a rapid response team, as these teams have the training and skillset to provide critical care 
in any clinical setting.   
Manuscript three is a paper that focuses on the issue of end of life care 
administered by nurse practitioners in a critical care setting.  This paper delves into the 
issues of what constitutes informed decision making on the part of the patient and their 
potential surrogates, ethical dilemmas, evidence based recommendations for 
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communication strategies, medication strategies, and the impact that the dying process 
can have on staff, patients, and their families.   
These three manuscripts highlight what this doctoral journey has provided me; an 
ability to assess the evidence and synthesize from it solutions to issues on a systems level, 
to evaluate the impact of those solutions, and the ability to speak competently about 
issues facing the profession.  I have gained a viewpoint that is elevated from the level of 
the individual to the level of systems and organizational.  This elevated viewpoint is only 
made possible by the principles and advanced education that formulate the Doctorate of 
Nursing Practice degree. Sir Isaac Newton said “if I have seen further it is by standing on 
the shoulders of giants”; I would say that I see farther now, due to the giants that have 
come in the profession before me and what I have learned from them.  It is my heartfelt 
hope that one day, I may be able to raise the awareness of others of our profession.  
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Manuscript One   
A Retrospective Quality Improvement Evaluation of the Utilization and Impact of a 
Nurse-Driven Bedside Sepsis Screening Tool at Baptist Health Lexington from February 
2015 through July 2015. 
Nicholas J. Welker, MSN, ACNP-BC 
 
 
University of Kentucky 
 College of Nursing 
 Spring 2016 
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Introduction: 
Traditionally, sepsis has been defined as a systematic inflammatory response 
syndrome (SIRS) to an infection, either localized or systemic in nature (Bone, 1992).  
The concept of sepsis has been imagined as existing on a continuum -- from sepsis, to 
severe sepsis, to septic shock -- with a steady progression to greater and greater severity 
of illness.  Severe sepsis is when sepsis is associated organ dysfunction; septic shock is 
when there is organ dysfunction in the presence of hypotension that is refractory to 
volume resuscitation.  For the purposes of this paper when referring to all forms of sepsis 
we will use the term “sepsis syndromes”. 
Figure 1 - Venn Diagram of Relationship Between Infection, Sepsis Syndromes, and 
SIRS 
 
Copied from Angus, et al., 2001 
The initial stages of sepsis can be insidious and difficult to differentiate from 
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other disease processes that also invoke an inflammatory response (Sebat, 2007; Robson, 
Beavis, & Spittle, 2007).  The inability to detect early sepsis is especially concerning 
when you consider that Sebat, et al (2005) found that 24 percent of sepsis syndrome cases 
initially developed on the medical-surgical floors where there is less access to critical 
care services in the event of a rapid decline in clinical condition. 
In 2012, there were over a million in-hospital cases of which sepsis syndromes 
were the primary diagnosis (Celeste, 2013), with an annual increase of 6 percent in 
hospital cases of sepsis syndromes since 2001 (Elixhauser, 2011).   A diagnosis of a 
sepsis syndrome is the most expensive condition treated in the United States for all 
payers at an aggregate cost of almost $20.3 billion annually (Celeste, 2013).  Mortality 
can also be highly variable, with higher mortality rates being associated with higher 
severity of illness (Guidet, 2005), though the national average is 16 percent (Dellinger, 
2013).  This mortality rate is approximately eight times higher than the average mortality 
rates of in-patient hospital stays for other diagnoses (Elixhauser, 2011).   Resource 
utilization and length-of-say (LOS) all increase in a “step wise” manner with severity of 
illness, with LOS almost doubling as patients moved from the 1st quartile of illness 
severity to the 4th (Adrie, 2005).  Drieher and associates (2012) found there to be 
demographical differences that were directly independently linked with all-sepsis 
mortality; male gender, African-American ethnicity, and advancing age.   
The Center for Medicare and Medicaid Services (CMS) identified sepsis 
syndromes as a major area for quality improvement in inpatient hospital care.  CMS 
notified hospitals participating in the inpatient quality reporting program that data 
collection of the utilization of sepsis management bundles based off of the Surviving 
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Sepsis Campaign’s 2012 guidelines (Dellinger, et al., 2013) would begin October 1st of  
2015 (National Quality Forum, 2012).  The quality improvement data reported for 2015 
will be used for future payment determinations in 2017. 
The treatment of sepsis syndromes has been codified into a bundle of evidence-
supported guidelines by the Surviving Sepsis Campaign known as early goal directed 
therapy (EGDT) (Dellinger, 2013).  EGDT has been shown to decrease mortality, cost of 
care, length of stay , and disease progression (Castellanos-Ortega, 2010; Zubrow, 2008; 
Shorr, 2007).  EGDT is composed of several key interventions: prompt phlebotomy for 
blood cultures and perfusion markers, administration of intravenous antibiotics, and rapid 
fluid resuscitation (Dellinger, 2013).  Completion of these interventions within the initial 
six hours of diagnosis provides the most dramatically significant improvements in 
outcomes; however even then mortality remains approximately 40 percent or greater 
(Guidet, 2005; Castellanos-Ortega, 2010) for septic shock.  Guidet (2005) found 
unalterable characteristics such as age and comorbidities at roughly the same level in 
both severe sepsis and septic shock, leading the authors to propose that it is the alterable 
characteristics that are crucial in preventing disease progression, these being “prompt 
diagnosis and appropriate treatment.”  Despite knowledge of the importance of EGDT, 
implementation and compliance continues to be an issue for organizations, most often 
through an inability to coordinate the complex multidisciplinary care. 
Local Problem: 
Baptist Health Lexington identified they had a sepsis-related mortality rate 
consistent with the mortality rate found in other studies where there was no established 
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use of a sepsis care bundle (Castellanos-Ortega, 2010; Elixhauser, 2011; Nguyen, 2007).  
The Administration of BHL recognized that this was an actionable area of interest with a 
high level of impact on the institution and so began the process of instituting several 
initiatives with the goal of reducing inpatient sepsis syndrome mortality.  
Setting: 
Baptist Health Lexington (BHL) is a 383-bed, tertiary level hospital located in 
Lexington, Kentucky.  The hospital has numerous specialty services for patients with 
advanced disease processes or high complexity due to multiple comorbidities.  It has 
thrice been awarded Magnet status by the American Nurses Credentialing Center, is a 
Joint Commission-designated Primary Stroke Center, and was ranked as the #1 hospital 
in the Bluegrass region by U.S. News & World Report in 2014 and 2015. 
BHL provides multiple medical and surgical services, leading to a wide variety of 
admitting diagnoses.  In addition to the specialty services (i.e., cardiology, neurology, 
nephrology, etc) the hospital also has an in-house Hospitalist service for floor patients 
and mandatory Intensivist service involvement with all ICU patients.  Baptist Health 
Lexington is one of seven hospitals that comprise the Baptist Health system and is often a 
destination for patients requiring a higher level of care either due to illness severity or 
availability of services than can be provided at other facilities. 
Sepsis screening was rolled out incrementally across the organization: the 
Emergency Department (ED) in June, followed by the five intensive care units (ICUs) 
and eight medical-surgical floor areas in December.  The screening in the Emergency 
Department was performed once upon initial patient presentation; the screenings in the 
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ICUs and floors were performed at the beginning of every nursing shift on all patients 
who did not previously have a positive sepsis screen or a known diagnosis of sepsis.  
Once a patient screened positive for sepsis, the nurse would document “no more 
screening needed”.  The Baptist Health Corporation established organization-wide goals 
focused on reducing sepsis mortality by 25 percent. For BHL, this meant reducing sepsis-
related mortality from a baseline of 16.4 percent (based off of 2013 data) to 12.3 percent 
by fostering earlier detection and intervention of sepsis syndromes and increased 
compliance with EGDT.  
The Sepsis Interventions: 
 Several initiatives were undertaken to reduce mortality; an evidence-based sepsis 
screening tool was developed and implemented on all patients who presented to the ED, a 
sepsis order bundle was developed based on the 2012 Surviving Sepsis Campaign 
guidelines, and a sepsis screening tool similar to that utilized by the ED was implemented 
in the ICUs and on the medical floors. 
 The sepsis screening initiative in the ED was launched in June 2014.  During 
triage, nursing staff assessed patients for evidence of a known or suspected infection. If 
infection was known or suspected, then the nurse would look for evidence of a systemic 
inflammatory response.  If the patient met two or more criteria, then that patient met the 
technical definition for a sepsis syndrome and the nurse was required to inform the ED 
physician, who would then either refute or confirm the diagnosis and begin therapy.  If 
there was evidence of hypotension, then the patient met the criteria for severe sepsis, and 
the nurse was again required to inform the ED physician. 
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In keeping with the Surviving Sepsis recommendations on treating sepsis 
(Dellinger, et al.,  2012), a sepsis order set was developed that “bundled” together all the 
different treatment modalities required for treating sepsis: diagnostic, pharmaceutical, 
nursing care, and laboratory orders. This order set was available for provider use in 
August of 2014.  A computerized sepsis order set (SOS) was also implemented at the 
same time.    The last initiative to be phased in was a screening tool for the ICUs and 
medical-surgical floors; this tool was based on the ED screening tool.  This screening tool 
was initiated in December 2014.  Each shift had to complete the screening tool on all 
patients who did not have a prior positive screening for sepsis or a known sepsis 
diagnosis.  The purpose of this study was to evaluate the effectiveness of this nurse-
driven bedside sepsis screening tool and to determine what impact it had on the patient 
outcomes of mortality and ICU utilization.  As screenings were not performed on sepsis 
syndromes that were present upon admission, we analyzed patients with sepsis 
syndromes that developed after their first 24 hours of admission.  The bedside sepsis 
screening process is shown in Figure 2. 
Design Model: 
For the purposes of this study we shall be utilizing the Donabedian quality-of-care 
framework (Donabedian, 1988).  We shall analyze how the Structures component of staff 
knowledge and utilization of the bedside sepsis screening tool impacts the Process 
component of compliance with early goal directed therapy on the Outcomes of sepsis 
severity, mortality, and intensive care utilization.   Donabedian (1988) defines Structure 
as “the attributes of the setting in which care occurs”.  These attributes include the 
material resources available for the provision of care, the individual human attributes of 
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those providing care, and the attributes of the  organizational structure that frames the 
provision of care.  Donabedian defines Process as “what is actually done in giving and 
receiving care”; processes such as determining a diagnosis through a screening tool or the 
provision of therapy fall under this designation.  See Figure 3 for a visual representation 
of the model. 
Study Questions: 
1.  What is the percentage of patients with sepsis syndromes identified through the 
bedside screening process? 
2. What is the percentage of compliance with early goal directed therapy (EGDT)? 
3. What impact did the bedside sepsis screening tool had on the outcomes of 
mortality, intensive care utilization and length of stay, and sepsis progression as 
measured by sepsis-to-advanced-sepsis ratios? 
Ethical Issues: 
This study was reviewed and approved by the Baptist Health Lexington 
Institutional Review Board. 
Method of Evaluation: 
Baseline data was obtained on patients who had been admitted from July 1, 2014 
to December 31, 2014 and were discharged with a diagnosis of a sepsis syndrome that 
developed after the first 24 hours period of hospital admission.  This dataset was 
compiled based off of patient claims data obtained for the purpose of hospital billing.   
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Investigational data was collected on patients who were admitted from February 
1, 2015 to July 31 of 2015 and had a discharge diagnosis of a sepsis syndrome that was 
not present within the first 24 hours after admission.  Though the sepsis screening tool 
had been initiated  in  January, the decision was made to begin data collection in 
February to avoid bias due to unfamiliarity with the screening tool.  The decision was 
made to exclude patients who had a “do not resuscitate” (DNR) order as there may have 
been other limitations on care options that would not be noted in the records.  A total of 
26 cases that met study criteria were identified.  Patient demographical data including 
age, race, gender, were collected.  Outcome data included initial sepsis severity, 
maximum sepsis severity, length of stay in an intensive care unit, and mortality.   
All cases that were determined to have developed a sepsis syndrome within the 
study period had an electronic chart review which identified if the patients were 
appropriately screened for sepsis, the date and time of sepsis identification, by whom the 
sepsis syndrome was identified, were requisite laboratory tests performed within the 
prescribed timeframe, were antibiotics initiated within the prescribed timeframe, was the 
desired amount of intravenous fluids given within the prescribed timeframe, and were 
there signs of sepsis in the 24 hours prior to identification.     
Analysis: 
Descriptive statistics were collected on the 26 cases that met study criteria.  The 
sample size lacked sufficient power to detect significant differences.   
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Figure 2 - Bedside Nurse-Driven Sepsis Screening Steps
 
 
1.  Two or more Systemic Inflammatory Response 
Syndromes present 
•Temperature > 100.9 or < 96.8                                 
•Heart Rate > 90  
•WBC > 12 or < 4 
•SBP < 90  mmHg or Mean Arterial Pressure < 65 mmHg 
•Respiratory Rate > 20/min 
•Acute Mental Status change 
•Blood glucose > 140 in the absence of Diabetes  
 2.  Does the patient have signs of infection? 
•Cough/Sputum/Chest Pain 
•Adomnial pain/Distension/Diarrhea 
•Line or Device infection 
•Dysuria/Cloudy Urine 
•Headache with neck stiffness 
•Wound Infection/Cellulits 
•Other 
3.  Signs of organ dysfunction? 
•Lactate > 2 mmol/L 
•Systolic Blood Pressure < 90 mmHg or Mean Arterial Pressure < 65 
mmHg 
•Urine output < 0.5 ml/kg/hr for 2 hours 
•Oxygen < 90% on room air 
•Creatine > 2 mg/dl 
•Bilirubin > 2 mg/dl 
•Platelet count < 100 
•International  Normalized Ratio (INR) of  1.5 
 
If YES to 1 & 2, patient screened POSITIVE for SEPSIS.  
Notify Practitioner 
If YES to 1, 2, & 3,  patient screened POSITIVE for SEVERE 
SEPSIS.  Notify Practitioner STAT 
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Figure 3 - Donabedian Quality-of-Care Framework
 
Results: 
 Between the months of February through July of 2015, twenty-six cases of sepsis 
were identified as having developed after the subjects had been hospitalized for more 
than 24 hours.  The demographics for this group matched those of the baseline group 
which was obtained from July through December of 2014; predominantly Caucasian, an 
average age of 59.4, and a majority of males (See Table 3). Figure 4 shows the number of 
cases and if they were admitted to an ICU or medical floor upon time of diagnosis.  Table 
1 compares the findings for the baseline group of 24 patients in 2014 to the findings of 
the 26 patients who could have been screened in 2015. 
Screening Compliance: 
 In 2015 all hospital inpatients that did not already have a known diagnosis of 
Donabedian Model 
 
 
Structures 
Processes 
-EGDT 
 - Bedside Screening  
Outcomes 
-Sepsis Severity Ratio 
-Mortality 
-Intensive Care Utilization 
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sepsis present on admission were screened by nursing staff once a shift.  Ideally, the 
sepsis screen should be the first to identify any development of hospital acquired sepsis.  
To evaluate the effectiveness of the screening at identifying sepsis syndromes, we 
analyzed the 26 cases of sepsis syndromes that developed while the subject was 
hospitalized between February and July of 2015. 
Table 1- Demographics 
 2014 Data  (n=24) 2015 Data          (n=26) 
 N % N % 
Sepsis  5  20.8% 10  38.5% 
Severe Sepsis 12  50.0% 11  42.3% 
Septic Shock 7  29.2% 5  19.2% 
Severe Sepsis+ septic 
shock/sepsis ratio 
3.8 1.6 
Mortality  6  25% 0 0% 
Average ICU LOS (Days) 12.04 11.00 
Number of transfers to ICU 12 50% 11  42.3% 
Average Age (years)  66.2 59.4 
Race 100 percent Caucasian 84.6 percent Caucasian 
Gender 75 percent Male 61.5 percent Male 
LOS = Length of stay, ICU = Intensive Care Unit 
 The screening tool succeeded in identifying only six (23.1 percent) of the 26 cases 
of sepsis syndromes that developed in hospital.  The nursing staff were unable to identify 
evidence of sepsis syndromes as defined by the presence of two systemic inflammatory 
response syndromes with evidence of infection, within 24 hours of development in ten 
cases (38.5 percent). 
In eight cases (30.7 percent) the nursing staff had inappropriately ceased 
performing sepsis screening prior to the patient developing a sepsis syndrome.  Two 
patients (7.7 percent) did not meet screening criteria and were identified as having a 
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sepsis syndrome via other means.  Eighteen patients (69.2 percent) met criteria for 
systemic inflammatory response within the 24 hour period preceding identification of 
their sepsis syndrome but were not documented.     
Figure 4 - Monthly Number of Cases (n=26) and Location at Point of Sepsis 
Identification 
 
Compliance with early goal directed therapy: 
Early goal directed therapy (EGDT) is composed of several components; serial 
lactic acids, blood cultures, antibiotic administration, and volume resuscitation.  
Complete compliance with all EGDT components in the 26 cases of sepsis syndromes in 
hospitalized patients was extremely low at 7.7 percent (n=2).  The components with the 
highest compliance were antibiotic administration within 3 hours of identification (57.7 
percent, n=15) and blood culture obtainment within 1 hour of identification (57.7 percent, 
n=15).  Initial obtainment of lactic acid within the first hour of identification occurred in 
0
1
2
3
4
5
6
7
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Medical Floor
Intensive Care Unit
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6 patients (23.1 percent), with a drop in compliance to 2 patients (7.7 percent).  Only 7 
patients (26.9 percent) received a minimum of 2 liters of intravenous fluid resuscitation in 
less than 3 hours.  Seventeen patients were on the medical-surgical floors when their 
sepsis syndrome was identified, ten of which required transfer to the intensive care unit 
(58.8 percent).  Nineteen of the 26 patients identified in this study had intensive care unit 
stays with an average length of 264 hours (11.0 days). 
Very rarely was complete compliance with every component of early goal 
directed therapy (EGDT) obtained.  The majority of the patients received none (42.3 
percent) or only one (30.8 percent) of the recommended therapy components, with only 
7.7 percent receiving all EGDT components.  We get a more nuanced viewpoint of 
compliance with EGDT when we look at compliance rates with the individual 
components of EGDT: phlebotomy, antibiotic administration, and volume resuscitation.   
Compliance with the laboratory component (serial lactic acids and blood cultures) 
was variable.  As previously noted, compliance was much higher with blood culture 
obtainment (57.7 percent) versus compliance with the initial lactic acid draw (23.1 
percent) and the follow up lactic acid level (7.7 percent).  Monthly compliance for blood 
culture obtainment varied from 33 to 100 percent. 
Compliance with initial lactic acid obtainment varied from 50 percent to 0 
percent, with obtainment of the second lactic acid level happening once in March and 
again in July.  See figure 7 for a visual representation of monthly laboratory compliance.  
There does not appear to be a pattern to compliance with this component. 
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Figure 5 - Effectiveness of Bedside Screening at Identifying Hospital Acquired Sepsis 
Syndromes (n=26) 
 
   
Table 2 - Early Goal Directed Therapy Compliance and Outcomes 
 Hospital acquired sepsis 
syndrome cases (n=26) 
 N % 
Lactic acid level drawn within 1 hour of positive screening 6 23.1 
2nd Lactic acid level drawn within 6 hours of 1st  2 7.7 
Blood cultures drawn within 1 hour of positive screening 15 57.7 
Empiric antibiotics given within 3 hours of positive screening 15 57.7 
2000 ml of intravenous fluid given within 3 hour of positive 
screening 
7 26.9 
Located in Intensive Care Unit when identified 9 34.6 
Patients moved to Intensive Care Unit after positive sepsis 
screening (n=17)  
10 58.8 
Average Intensive Care Unit time (days)         11.0 N/A 
 
Negative Screen 24 
hours after 
evidence of sepsis 
38.5% 
False "do not 
screen again" 
30.7% 
Detected by other 
Medical Provider 
7.7% 
Positive screen 
23.1% 
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Antibiotic administration was one of the components with a consistently higher 
compliance rate of 57.7 percent.  Monthly compliance (as seen in figure 8 below) varied 
without a discernable pattern between 33 and 80 percent.    There was poor overall 
compliance (26.9 percent) with intravenous resuscitation with an infusion of a minimum 
of two liters of isotonic fluids.  Monthly compliance with this component of therapy 
varies from 50 percent to zero percent, with no discernable pattern (see figure 9).  It 
should be noted that achieving compliance with these components relies on other 
disciplines that nursing and could be a potential confounding factor. 
Figure 6 - Laboratory Compliance with Early Goal Directed Therapy (n=26) 
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Figure 7 - Empiric Antibiotic Compliance (n=26) 
 
Figure 8 - Intravenous Hydration Compliance (n=26) 
  
Mortality, intensive care utilization, sepsis syndrome ratios: 
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of cases of mortality, a lower ratio of advanced sepsis (severe sepsis and septic shock)-to-
sepsis ratios, and ICU length of stay (LOS).  The patients studied in 2015 had similar 
demographic composition as those in 2014.   
            The monthly percentages of sepsis-related mortality that met inclusion and 
exclusion  criteria are shown below (figure 16).  This chart shows what percentage of 
sepsis syndrome cases each month experienced mortality before and after the initiation of 
the bedside sepsis screening.  It should be noted that a zero percent mortality does not 
reflect the clinical reality that some patients will die with a sepsis syndrome and the 
significance of these results must be carefully considered.  
Figure 9 - Sepsis Related Mortality 
              
              Average intensive care unit (ICU) length of stay (LOS) decreased from 12.04 in 
2014 to 11.00 in 2015.  When the average monthly LOS is charted out (see figure 17) 
there does not appear to be a consistent pattern to the reduction in ICU LOS.  
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               A ratio of advanced-sepsis-to-sepsis was utilized as a method of determining if 
the screening tool was identifying sepsis syndromes early and leading to a prevention of 
disease progression.  If the screening process was identifying sepsis earlier and 
preventing the development of more advanced forms of sepsis (severe sepsis and septic 
shock), then we would see an increase in cases of sepsis and a decrease the cases of 
advanced sepsis.  We could express this relation numerically by viewing it as a ratio; the 
cases of sepsis being the denominator and the cases of advanced sepsis (severe sepsis and 
septic shock) as the numerator.  The ratio for 2014 was 3.8 (19 cases of advanced sepsis 
divided by 5 cases of sepsis) and 1.6 (16 cases of advanced sepsis divided by 10 cases of 
sepsis) in 2015.  A visual representation of this relationship between sepsis syndromes 
and their frequency can be seen in figure 18 below. 
Figure 10 - Intensive Care Unit Length of Stay (Days) 
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             In 2015 there was a lower intensive care unit (ICU) length of stay (12.04 versus 
11.00 days), fewer cases of mortality (25 versus 0 percent), a lower severe sepsis/septic 
shock-to-sepsis ratio (3.8 to 1.6) and percentage of patients requiring ICU admission 
(50.0 versus 42.3 percent) for patients with hospital-acquired sepsis syndromes over the 
time period after the bedside nursing screening was initiated.  The data reflect early 
trends but are limited by the short time period of data collection. We need to monitor the 
data over time to see if the trends continue.   
Figure 11 - Sepsis/Severe Sepsis/Septic Shock Ratio 
 
Discussion:  
This study is a retrospective review of sepsis outcomes at Baptist Health 
Lexington from February 2015 through July 2015 for the purposes of evaluating the 
effectiveness of a bedside nursing driven sepsis screening tool and identifying potential 
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quality improvement.  An analysis on the effectiveness of the bedside nursing screening 
tool was performed by reviewing the 26 cases of sepsis syndromes that developed while 
the subjects were hospitalized; the cases the screening tool was specifically designed to 
identify.  There were no significant variations in demographical composition.       
Percent Identified by Screening: 
There were multiple reasons for the failure of the screening process to identify 
sepsis syndromes at BHL; the two major reasons were a failure to recognize 
physiological changes that indicated the presence of a sepsis syndrome (38 percent) and a 
failure to utilize the tool properly, leading to an early cessation of screening (31 percent).  
It could be argued that the nurse may have recognized the presence of a sepsis syndrome 
at some point other than when the screening was performed, hence leading to the “prior 
screen positive, cease screening” option being chosen.  If this were the case, however, the 
nurses still obviously did not understand how to appropriately document the change in 
condition.  An additional possible cause for failing to capture sepsis diagnoses is that 
nurses may have felt uncomfortable with declaring that a patient had a 
“known/suspected” infection, or that the nurse lacked the knowledge to make that 
declaration.  Several times the nurses noted a patient met SIRS criteria, but stopped the 
screening at the second phase question, “Does the patient have a suspected/known 
infection?”  Another finding that was noted in the chart review was that “already on 
antibiotics” was given twice as a reasoning why the provider was not notified of the 
possibility of a sepsis syndrome; this in no way addresses if the antibiotics are 
appropriate or effectively dosed to treat sepsis.  Further research is needed to determine 
the source of poor screening compliance amongst staff; examining staff attitudes about 
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the screening, understanding of the screening process, and identifying perceived and 
potential barriers to its utilization.    
This is not the first study to find low compliance with sepsis screening methods. 
Nguyen and associates (2007) found low compliance with a sepsis screening initiative in 
their study that they were able to rectify through a 2 year program of continuous staff 
education and the utilization of a team specializing in sepsis identification and treatment.  
Mikkelsen and associates (2010) also found that lack of sufficient knowledge amongst 
staff lead to poor compliance with their study’s screening protocols.  It is possible the 
initial staff education given was not sufficient enough to foster effective screening 
compliance.  It is also possible that what is needed is ongoing education with continuous 
feedback such as that described by Nguyen, et al (2007) to increase and maintain 
compliance.  It is also possible that the lack of a pilot trial of the screening tool to prove 
utility and establish potential barriers to utilization lead to the poor utilization rates; the 
utilization of pilot studies to foster organizational change has been well established in 
change models such as the Stetler Model (National Collaborating Centre for Methods and 
Tools, 2011).  The Stetler Model also suggests that the utilization of “change champions” 
is beneficial in fostering organizational change and adoption of new practices.   
Early Goal Directed Therapy Compliance: 
 Overall compliance with early goal directed therapy (EGDT) was poor in this 
group of patients.  The majority (42.3 percent) of patients did not receive any components 
of EGDT while only 7.7 percent had complete compliance with all EGDT components.  
The component that achieved highest compliance was prompt antibiotic initiation at 57.7 
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percent, with the phlebotomy component having the lowest compliance rate of 7.7 
percent.  As to be expected, failure to identify sepsis syndromes led to failure to treat 
sepsis syndromes.  When sepsis syndromes were identified by the screening process, 
compliance with administration of antibiotics improved, although this finding must be 
viewed with extreme caution as this subgroup was only 6 patients. Compliance with the 
other components of the EGDT protocol for these 6 patients was comparable to the total 
sample.  
 The administration of empiric antibiotics within three hours of sepsis syndrome 
identification was the component with the highest compliance of 57.7 percent of all 
patients.  In patients identified by the screening (n=6), the compliance with antibiotics 
was 100 percent versus 45 percent of those patients (n=20) whose sepsis syndromes were 
detected by other means.  Further research needs to be done into nursing staff to 
determine what their level of understanding of the need for prompt antibiotic therapy in 
sepsis syndromes and identify potential barriers to that.  Potential barriers to provider 
prescribing should be investigated as well; are they being notified, are they receptive of 
the information, do they foster open communication? 
Total compliance with medication administration is a multi-step process that 
relies on several different departments and providers, any one of which could cause a 
delay or failure in treatment.  Medical providers may not have been notified or the 
presence of a sepsis syndrome or lacked sufficient knowledge as to what is appropriate 
antibiotic therapy for the patient’s sepsis syndrome.  It is possible that the compliance 
failures may be the result of process failures in other areas such as pharmacy.  Potential 
causes for delays could be; lack of pre-mixed antibiotics, understaffing of pharmacy 
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personnel resulting in delays in processing orders and delivering them to the requisite 
clinical area, a failure in the process of delivering the medication into the hands of the 
nurse as quickly as possible.  The data were analyzed for compliance to the standard of 
having antibiotics administered within a three hour timeframe. It is possible that they 
were ordered but not administered within the time period. Further analysis is warranted to 
identify the source of the delay.     
When the phlebotomy component is broken down we find higher compliance with 
the obtaining of blood cultures (57.7 percent) than we do with obtaining the first serum 
lactic acid level (23.1 percent) and the second serum lactic acid level (7.7 percent).  It is 
possible that, since phlebotomy is undertaken by laboratory technicians versus nursing 
staff, there is a lack of understanding of the significance of drawing the second lactic acid 
within a specific timeframe.  An additional reason may be that, since the timing of the 
second lactic acid is conditional on when the first lactic acid was drawn, that uncertainty 
may have caused delay in ordering the second lactic acid level leading to further delays in 
obtaining the specimen.  Finally, as previously stated, lack of prompt detection of sepsis 
syndromes may have led to lack of EGDT initiation.  Compliance with obtaining blood 
cultures was 100 percent in the 6 patients whose sepsis syndromes were detected by the 
screening process versus the 45 percent in the group detected by other means (n=20), 
although the number of cases precludes the ability to determine the significance of that 
definitively. Follow up with members of the lab department is warranted to better 
understand their processes.  
 The administration of intravenous (IV) fluid resuscitation is the third component 
of EGDT.  This study found that only 7 cases (26.9 percent) received aggressive fluid 
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resuscitation of a minimum of two liters of IV fluids within three hours or less as per the 
Surviving Sepsis Campaign guidelines.  Reasons for failure to comply with this 
component can be complex as rapid volume resuscitation may not always be appropriate, 
depending on patients’ existing volume status and other disease processes such as renal 
or heart failure.  The rapid administration of intravenous fluids could also be delayed due 
to lack of access or insufficient access to provide both intravenous antibiotics and 
intravenous fluids at the same time.  A variety of individual clinical factors could delay 
achievement of this component; such as lack of sufficient intravenous access, the 
patient’s individual volume status, or the presence of a comorbidity which precludes 
rapid volume resuscitation. 
 Overall, compliance with early goal directed therapy (EGDT) was quite low.  
Additional research as to the root source of this failure to comply is needed.  It is possible 
that the source of the issue is a lack of staff understanding about sepsis and its treatment.  
It is also possible that there are a lack of established hospital processes that foster 
compliance with EGDT.  Studies by Nguyen, et al (2007) and Mikkelsen, et al (2010) 
found that continuous education and feedback improved staff understanding and 
compliance with EGDT.  Mikkelsen and associates (2010) also utilized a team of “sepsis 
specialists” who were deeply familiar with EGDT as a resource for staff, thereby 
improving compliance even more.      
Outcomes of Severity of Sepsis, Mortality and Intensive Care Utilization: 
 There was a potential improvement in sepsis related mortality from 25 percent 
(n=6) to  0 percent, though it is unclear that utilization of the bedside sepsis screening had 
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an individual impact on this due to the small number of patients.  It is also conceivable 
that the perceived mortality benefit is the result of some other cofounding variable such 
as the other sepsis reduction initiatives undertaken during this time period. For example, 
during this time period, there was a heightened awareness of sepsis management 
throughout the organization. Given that the data collection time period was limited to six 
months following the intervention and the number of cases is small, the trend is 
promising but may not accurately reflect an improvement. Thus, ongoing monitoring is 
needed to see if this trend continues.      
As this is a study on an intervention to detect the early onset of sepsis, the most 
desirable outcome would be to identify sepsis in nascence and intervene before it has had 
the opportunity to advance on to severe sepsis or septic shock.  To study this, we looked 
at several pieces of data; the ratio of advanced sepsis syndromes to sepsis, the number of 
cases that advanced in sepsis severity after the point of diagnosis, and the presence of 
systemic inflammatory response syndromes (SIRS) within 24 hours prior to the diagnosis 
of a sepsis syndrome being made.   
The literature suggests that early identification and treatment are able to diminish 
the chance of progression from sepsis to severe sepsis or septic shock.  We would see that 
the ratio of advanced-sepsis (defined as severe sepsis and septic shock) to sepsis ratio 
would decrease due to the increased discovery of cases of sepsis (the denominator) and 
the decreased cases of advanced sepsis syndromes (the numerator).  We find this to be the 
case as the advanced-sepsis-to-sepsis ratio in 2014 was 3.8 and decreased to 1.6 in 2015, 
although these results are too preliminary to establish a trend.  The main reason for the 
decrease was that the cases of sepsis increased from 20.8 percent of all sepsis syndromes 
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in the study period of 2014 to 38.5 percent for the study period of 2015.  The cases of 
severe sepsis and septic shock also decreased.  Due to the small number of cases in the 
study it is possible that small variations such as 3 less cases of advanced sepsis in 2015 
could have a deceptively large impact, ergo further investigation will be required. 
A reduction in the severity of sepsis should, hypothetically, lead to a reduction in 
intensive care unit (ICU) utilization; ICU length of stay (LOS) and transfers from 
medical floors to the ICU.  This study did find an average reduction in ICU LOS from 
12.04 days in 2014 to 11.00 days in 2015. If this trend continues and is not offset by a 
longer overall hospital stay, each ICU day avoided has the potential to save the hospital 
approximately $5,000 per patient.  
An important aspect of any screening tool is that it detects the presence of what it 
is looking for as soon as possible.  To assess if this was the case with the bedside 
screening tool we examined if the nurse had documented that the patient had evidence of 
systemic inflammatory response syndromes (SIRS) criteria within the 24 hours preceding 
the diagnosis of a sepsis syndrome, which is phase one of the screening protocol.  It does 
not appear that the bedside screening tool was effective in detecting the development of 
sepsis in a timely manner.  When the nurse is performing the sepsis screening, they are to 
document in stage one of the screening process if SIRS criteria are present.  This study 
found that, of the 26 cases in 2015, 18 (69.2 percent) had the undocumented presence of 
two SIRS criteria within the 24 hour period prior to them being identified as having 
developed a sepsis syndrome.  This is to be expected given the previously stated findings 
that there was low compliance with the screening process on the part of nursing staff.  A 
possible cause for this may be that it is no uncommon to find patients with SIRS in the 
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hospital population as it is a component of numerous other disease processes, such as in 
the post-surgical patient, which comprised 73.1 percent (19 cases) of the study 
population.  Since some SIRS criteria are to be expected, the nurse may not investigate if 
the patient has multiple criteria that may suggest the presence of a sepsis syndrome.  If 
the patient does meet SIRS criteria, it is then left up to the nurse to make the subjective 
determination as to if an infection is suspected or the presence of SIRS criteria is related 
to the primary reason for the patient’s hospitalization or the development of an additional 
sepsis syndrome.  This reliance on SIRS criteria as part of the screening process should 
be considered as a potential root cause of the problems with sepsis identification.  Recent 
research by Seymour and associates (2016) found SIRS criteria too ubiquitous in the 
hospital population to be of much utility for identifying the development of sepsis.   
Relation to other evidence:  
The finding of this retrospective quality improvement evaluation both agrees and 
differs with other evidence on this topic.  The evaluation did not show a variation in 
mortality between patients whose hospital acquired sepsis syndrome was identified via 
the nurse-driven sepsis screening tool and other means of identification.  Mortality in 
both groups was lower than that in 2014, which is consistent with a generalized 
downward trend in all-sepsis mortality noted by Moore and associates (2011).  This could 
be reflective of an incorporation of the principles of early goal directed therapy into the 
standard of care while not adopting strict adherence to the goals of the guidelines.  The 
patients studied had shorter ICU LOS as had been seen in previous studies (Zubrow, 
2008; Castellanos-Ortega, 2010, Shorr, 2007; & Levy, 2010).   
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Limitations: 
There are several limitations that must be acknowledged with this study.   
Electronic chart review ensured that no false cases were included, but there is no way to 
determine if there were cases of sepsis syndromes not included in this study due to 
miscoding.  That the study was performed at a single facility may indicate that the results 
would not be generalizable.  The limitation of the time frame to just one calendar year 
may have influenced by the other sepsis reduction strategies implemented.  The decision 
to exclude patients with Do Not Resuscitate orders may have introduced bias and lead to 
an underreporting of mortality.  The study is limited due to the small sample size which 
precludes the ability to achieve statistical power; however, continued data collection over 
time will yield sufficient power.  The narrow inclusion and exclusion criteria raises 
questions about the generalizability of the findings.   
Interpretations: 
There appears to have been an improvement in mortality between 2014 and 2015.  
Although there were few cases experiencing mortality in 2014, the further reduction to 
zero cases in the first six months of 2015 suggests that there was an improvement. Given 
the poor compliance with nurse screening and the EGDT protocol, the improvement does 
not seem to result from the screening process.  As it is highly unlikely that all sepsis 
mortality was reduced to zero, this improvement must be viewed as suspect and 
potentially the result of the very narrow focus of the study.  
The apparent lack of impact of the sepsis screening process is at odds with the 
conclusions of Moore and associates (2009) who found that a sepsis screening tool was 
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able to directly reduce their mortality by a third.  Key variances between their study and 
the experience at BHL may lie in their much higher compliance rates (consistently >70 
percent) and that they utilized a three-step process that involved a “midlevel practitioner” 
to do an additional assessment of the patient.  While that additional assessment may aid 
with confirming sepsis, it does not seem to be the issue here, as the nurse did not catch 
the sepsis diagnosis 73 percent of the time.   
Of the 26 cases of sepsis that developed while the patient was hospitalized, only 
23.1 percent were identified via the bedside sepsis screening; this represents a significant 
failing on the part of the screening process.  Further work needs to be done on identifying 
the root causes of the nurses failing to utilize the screening process appropriately.  
Compliance with early goal directed therapy (EGDT) for sepsis syndromes was very 
poor, with 42.3 percent receiving none of the components of EGDT and only 7.7 percent 
being completely compliant.  There was a reduction in advanced-sepsis-to –sepsis ratios; 
however this seems to be the result of a greater identification of sepsis rather than a 
reduction in the advancement of sepsis to its more severe incarnations.  The presence of a 
sepsis screening tool failed to aid identification of evidence of SIRS criteria in 69.2 
percent (n=18) of subjects within the 24 hours prior to diagnosis of a sepsis syndrome.  
There was a reduction in intensive care unit length of stay (ICU LOS) of 1.04 days but 
the small size of the study does not allow us to definitively state that this is due to the 
intervention and not either due to some other confounding factor or simple chance.  That 
being said, we do have a clinically significant improvement in the outcome of ICU LOS 
with a potential cost savings of over 4000 dollars for that one ICU day saved (Chalupka, 
2012).  
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Recently released evidence has called in to question the effectiveness of EGDT as 
a means of reducing mortality versus standard care, although these results may reflect 
that the standard of care has finally incorporated the key components of EGDT that 
impacted mortality, such as prompt empiric antibiotic administration and utilization of 
appropriate biomarkers to guide therapy.  New evidence has just come out in late 
February of this year that our traditional definition of sepsis, that of a systemic 
inflammatory response in the presence of infection, is not specific enough, requiring a 
new definition focusing on the presence of organ dysfunction with concomitant infection 
(Abraham, 2016).  It is too soon to know how this new evidence and definition will shape 
the conversation and treatment of sepsis syndromes, but it is certain to alter how patients 
are identified and what future goals of effective evidence-based therapy will look like.       
Finally, it should be noted that, while it is a significant cause for concern when a 
patient develops a sepsis syndrome while they are hospitalized, the fact remains that this 
is not a significant proportion (4.8 percent) of the overall incidence of sepsis within the 
hospital (n=542).  The institution may be better off investing its energy into other means 
of reducing sepsis within the hospital setting such as improving hand hygiene amongst 
staff, adherence to aseptic technique, and fostering processes that enhance and empower 
nursing clinical judgement.  
Recommendations: 
The impact of the screening tool was limited due to poor utilization rates.  Further study 
is needed on analyzing potential causes for nursing staff failing to appropriately utilize 
the screening tool.  More information is needed about the bedside nurse’s experience 
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utilizing and interacting with the screening process to identify potential issues leading to 
poor screening compliance.  Some potential causes for poor screening compliance could 
include; an insufficient initial educational experience, potential lack of feedback, 
unidentified barriers to utilizing the screening tool, lack of clarity in the construction of 
the screening tool, an over-reliance on the subjective “suspicion of infection,” a lack of 
empowerment on the part of nursing to diagnose a patient as having a sepsis syndrome.  
The nursing staff should be approached to identify potential barriers to compliance with 
early goal directed therapy such as lack of established supportive processes, insufficient 
manpower available, or possibly delays within other disciplines.  Several other 
recommendations as to how to improve compliance and EGDT administration are:  
1. BHL should explore the reasons for nurses’ inability to utilize the bedside screening 
tool and target an educational investment to improve staff understanding of the tool, 
signs and symptoms of sepsis syndromes and, if need be, what constitutes a 
“suspected” infection. 
2. Evaluate continued use of the “no more screening required” option to reduce missed 
cases.   
3. Repeat staff education about the sepsis screening tool and reinforce education on a 
frequent basis. 
4. Root cause analysis should be conducted so as to identify potential barriers to 
compliance with all components of early goal directed therapy for every discipline 
involved. 
5. Initiate monitoring of sepsis screening compliance and provide nursing feedback on 
compliance rates in a timely manner so as to impact behavior. 
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6. Baptist Health Lexington should consider whether they wish to increase the 
specificity of the screening tool for identifying sepsis by increasing the requisite 
number of Systemic Inflammatory Response Syndrome (SIRS) criteria with their 
current screening tool or transition to a different sepsis screening tool such as qSOFA 
so as to more accurately capture sepsis syndromes when they occur. 
Conclusions: 
A retrospective quality improvement review was performed of the 26 cases that 
met criteria between the time period of February and July of 2015.  This review found 
that the screening tool only succeeded in identifying 23.1 percent of the cases; the two 
main reasons for failure being an inappropriate cessation of screening and a failure to 
identify the physiological signs of sepsis development. The presence of SIRS criteria 24 
hours prior to identification of sepsis was undocumented in 69.2 percent of patients.  
Overall compliance with early goal directed therapy (EGDT) was only 7.7 percent with 
42.3 percent of patients receiving no EGDT within the proscribed timeframe.  There was 
a reduction in average length of stay within the intensive care units of 25 hours (1.04 
days).  Mortality was lower in 2015 than it had been in 2014 (zero percent versus 25 
percent), but such a profound reduction is incongruous with the fact that there was still 
mortality related to sepsis at Baptist Health Lexington during this timeframe.  It is more 
likely that, even if there was a reduction in mortality, the small sample size and the 
decision to exclude all patients with DNR orders underrepresented patients who died.  
Further sepsis research utilizing mortality as an outcome should   Further investigation 
needs to be done to identify the nurses’ experience in utilizing the screening tool and 
determine possible barriers to its effective utilization.  Identification and removal of 
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barriers to sepsis identification may or may not have a positive impact on EGDT 
compliance and further investigation into changes in processes to foster EGDT 
compliance may also be warranted.    
 37 
 
Manuscript Two 
Review of Evidence on Feasibility of a Rapid Response Team as a Conduit for Providing 
Early Goal Directed Therapy in Sepsis 
Nicholas J. Welker, MSN, ACNP-BC 
 
 
University of Kentucky 
College of Nursing 
Spring 2016 
  
 38 
Background: 
Sepsis is a systemic inflammatory response syndrome (SIRS) to an infection, 
resulting in a wide variety of physiological abnormalities (Bone, 1992).  Sepsis can be 
imagined as existing on a continuum: from sepsis, to severe sepsis, to septic shock, with a 
steady progression to greater and greater severity of illness.  Severe sepsis is sepsis with 
associated organ dysfunction; septic shock is organ dysfunction in the presence of 
hypotension that is refractory to volume resuscitation. This progressive disorder of body 
systems leads to a “point of no return,” where the organ damage from the shock state is 
irreversible and will lead to inevitable decline and death (Funk, Sebat, & Kumar, 2009). 
 The incidence of severe sepsis in 2001 was approximately 750,000 cases annually 
(Angus, 2001) with an average increase of approximately six percent (Martin, 2003) to 
over a million cases in which septicemia was the primary diagnosis in 2012 (Celeste, 
2013).  The steadily increasing rate in cases is felt to be due to multiple factors: the aging 
of the population, more utilization of invasive procedures, high rates of comorbidities in 
the population, immunosuppressive therapies, and the growing burden of antibiotic 
resistant organisms (Martin, 2003).  The mortality rates for sepsis also increases in the 
presence of additional co-morbidities and as patient age increases (Yang, 2010).  
Considering that there are unalterable drivers such as age and comorbidities, the clinical 
importance of sepsis will only increase as the population ages.   
Significance:   
The mortality rate of sepsis is highly variable and ranges from 28% to 40% 
(Angus, 2001; Estaban, 2007), depending on alterable and unalterable patient 
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characteristics; age, comorbidity status, type of infection, level of organ dysfunction, and 
alacrity of appropriately directed therapy.  Mortality also increases with each 
advancement a patient makes in the continuum from sepsis, to severe sepsis, to the 
highest mortality being in patients with septic shock (Guidet, 2005).  Adrie (2005) found 
a similar “step-wise” increase in the cost of care associated with the progression of illness 
severity, the higher the age, and the presence of co-morbidities. 
Sepsis is the most expensive condition treated in the United States for all payers 
(Celeste, 2013) at an aggregate cost of almost 20.3 billion (Elixhauser, 2011) dollars 
annually.  A root-cost analysis study (Merritt, 2011) found that the care of sepsis patients 
already comprised 40% of total institutional costs of Intensive Care Unit (ICU) 
admission, with the care of a patient with sepsis costing six times more than the care of 
an equivalent ICU patient.  Shorr, et al. (2007) found the direct costs of care for a patient 
with sepsis to be highly variable but with a median cost of $21,956, partially due to a 
longer hospital length of stay (LOS).  Teres, et al. (2002) found that resource utilization 
and LOS increased with severity of illness, with LOS almost doubling as patients moved 
from the 1st quartile of illness severity to the 4th quartile.   
Early Goal-Directed Therapy: 
The standard of care for sepsis has been codified into an evidence-based bundle of 
interventions called Early Goal Directed Therapy (EGDT). This bundle was developed 
for the Surviving Sepsis Campaign (Dellinger, 2013) and has been shown to decrease 
mortality, cost of care, length of stay, and disease progression (Castellanos-Ortega, 2010; 
Zubrow, 2008; Shorr, 2007).   
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EGDT is focused initially around several central interventions; prompt 
phlebotomy for blood cultures and perfusion markers, administration of intravenous 
antibiotics (ideally within the first hour of therapy), and rapid fluid resuscitation 
(Dellinger, 2013).  Completion of these interventions within the initial 6 hours provides 
the most statistically significant improvements in outcomes; however even then mortality 
remains approximately 40% or greater for those with septic shock (Guidet, 2005; 
Castellanos-Ortega, 2010).  Guidet (2005) found that unalterable characteristics such as 
age and comorbidities did not have an impact on sepsis severity, leading the authors to 
propose that it is the alterable characteristics that are crucial in preventing disease 
progression, these being “prompt diagnosis and appropriate treatment.”  Kumar, et al 
(2006) supports the need for rapid identification and treatment by showing that for every 
hour past identification of severe sepsis, mortality increases 7%.  Obviously, elimination 
of the pathogenic organism is just as vital in the early treatment of sepsis as volume 
resuscitation.   
If mortality remains high even with appropriate treatment, greater steps need to be 
taken to promote prompt and earlier diagnosis.  The majority of the literature has focused 
primarily on improving the timeliness and quality of interventions after sepsis is already 
present, most often in its more severe forms.  What evidence does exist about 
surveillance and screening for sepsis is focused predominantly on screening protocols 
developed for the Emergency Department upon initial patient presentation, which ignores 
the population of patients that are already admitted to the hospital.      
Sebat, et al (2005) found that approximately 24% of patients who developed 
severe sepsis or septic shock originally did so while on a medical-surgical unit, therefore 
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efforts to increase surveillance and early identification in this setting are highly desirable.  
By identifying sepsis in its early stages, it can be presumed that staff will be able to 
institute standing policies early in the disease course, when it is most responsive to 
EGDT.  Strong evidence suggests that the speed at which appropriate EGDT therapies are 
initiated following the recognition of hypotension may be the single strongest predictor of 
survival (Kumar, et al, 2006; Lundberg, et al, 1998).  It is evident that it is not just if 
EGDT is initiated, but when that is crucial in preventing irreversible shock and 
subsequent organ damage and failure.  An analogy would be that is it is better to have 
active surveillance with a smoke detector than to wait until your house is visibly on fire 
to start intervening.  Keeping within that analogy: the longer you delay intervening, the 
less likely your house is to survive, even if you eventually get the fire under control.  
Appropriate care for the septic patient requires both quick identification and swift 
initiation and coordination of multidisciplinary treatments.   
Rapid Response Teams: 
The Rapid Response Team (RRT) or Medical Emergency Team (MET) was 
developed to intervene in patients experiencing deterioration despite the presence of 
existing clinical services (Devita, 2006).  In accordance with the “100,000 lives” 
campaign, RRTs can be initiated by staff, patients, or family members whenever there is 
subjective or objective evidence of an acute change in the patient’s health status.  The 
guiding premise is that certain objective and subjective triggers can be utilized in alerting 
a multidisciplinary team to the clinical deterioration of a patient.   
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The composition of these teams can vary widely, but the core staff is traditionally 
composed of one or more nurses with critical care background and representatives from 
other ancillary services such as radiology, phlebotomy, and respiratory therapy.  They 
may or may not have a pharmacist, physician, or other advanced practice provider 
(Benson, Hasenau, O’Conner, & Burgermeister, 2014).  These teams often have protocols 
that are utilized to guide team members’ actions and empower them to initiate a limited 
scope of appropriate interventions without physician oversight (Lienhop, Kaplan, & 
Gray, 2008).   
The goal of an RRT, regardless of the composition, is to swiftly provide a higher 
level of care to patients outside of traditional intensive care areas, such as the medical 
wards, hospital grounds, and associated hospital environs such as offices or imaging 
areas.  The intention of a RRT is to stabilize the patient where they are and evaluate if the 
patient can safely remain at their current level of care or requires transition to a higher 
level of care such as an ICU.   
Rapid Response Teams usually follow established protocols based on disease 
processes that are best treated within the narrow window of time in which specific care is 
required to avoid a negative outcome such as trauma, cerebral vascular accident, 
myocardial infarction, and shock syndromes (Devita, 2006).  Unlike these other 
syndromes, however, the signs of sepsis can be subtle, easily missed, and difficult to 
diagnose, requiring specifically tailored education and protocols (Funk, Sebat, & Kumar.  
2009).  These protocols are commonly evidence-based, but are institution specific and 
may vary in what disease processes they cover, and the available testing and interventions 
that may be initiated without input from additional non-RRT providers.    
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The concept of bringing additional expertise and resources to patients in crisis so 
as to avoid a worsening of a patients’ clinical situation is consistent with the core 
concepts of the Surviving Sepsis Campaign (Dellinger, 2013).  A RRT provides the 
multidisciplinary knowledge and competencies that allow for prompt identification of 
patients with sepsis, and initiation of EGDT as soon as possible so as to be able to 
complete it within the target window of 6 hours.   The purpose of this review of literature 
is to explore the utilization of a rapid response team as a vehicle for providing early goal 
directed therapy as quickly and completely as possible and determine what impact it may 
have on the outcomes of hospitalized patients who develop sepsis.   
Inclusion and Exclusion Criteria: 
A search of the CINAHL and PUBMED databases was performed utilizing the 
keywords “systemic inflammatory response syndrome,” “sepsis,” “severe sepsis,” “septic 
shock,” “sepsis syndromes,” “rapid response teams,” “rapid response systems,” “medical 
emergency teams,” “early goal directed therapy.”  The following filters were used: 
articles had to be published within the last 15 years, available in English, and dealt with 
an adult population exclusively.  This resulted in a total of 43 articles in CINAHL and 35 
articles in PUBMED.  A secondary review was performed utilizing the bibliography of 
relevant articles identified an additional 5 articles that had fallen out of the inclusion 
parameters that were deemed eligible. 
Screening Process of Study Eligibility: 
The total results of the database searches were compiled and repeat articles were 
removed (n =20).  Twelve articles that did not separate sepsis out as an identified source 
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of shock were excluded.  Twenty-four articles where the responding RRT did not identify 
if interventions provided to septic patients were compliant with EGDT were excluded as 
well so we could be certain to be comparing interventions.  Fourteen articles were 
excluded where it was not identified if there was a method of screening/identifying sepsis 
upon initiation of RRT so as to not include articles treating other sources of hypotension 
such as cardiogenic shock.  This left a total of 9 articles.   
Results: 
 Evidence has shown that the earlier you identify and initiate treatment on septic 
patients, the lower the mortality, length of stay (LOS), and cost of care (COC) (Dellinger, 
2013).  The wider sepsis literature has found that there can be a disconnect between 
ordering and initiating EGDT and its completion within the prescribed time frame, 
leading to negative outcomes for patients in severe sepsis (Berg, 2011).   
The review of literature has found that, for the most part, a RRT response has a 
positive effect on patient outcomes.  Several major themes have repeatedly been found 
across these studies; the use of a rapid response team to identify sepsis and initiate EGDT 
provides quicker and more complete EGDT implementation, decreased mortality, 
decreased ICU utilization, decreased LOS, quicker sepsis identification, and an increase 
in patients who are discharged to home as opposed to standard care methods.   
Mortality: 
Every article that analyzed the impact of a RRT on the initiation of EGDT found a 
statistically significant positive impact.  Blumstein and Jones (2013) found a reduction in 
their “risk-adjusted mortality index from 1.8 to less than 1.25”.  Lienhop, Kaplan, and 
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Gray (2008) found a 16% decrease in their sepsis mortality over 6 months, which is on 
par with the results of Sebat, et al (2007) which found a 18.6% absolute reduction in 
mortality, with a relative reduction of 46.6%.  This built on the authors’ earlier work 
(Sebat, et al., 2005) which at that point only showed a 12.5% absolute reduction in 
mortality with a relative reduction of 31%.  These reductions are not to the same scale as 
that found by Zubrow, et al (2008) who found a 49.4% reduction in mortality in their 
severely septic patient population!  These results are in contrast with the work of Benson, 
Hasenau, O’Conner, and Burgermeister (2014) which found no impact on patient 
mortality.    
Resource Utilization: 
 Several studies showed that the incorporation of a RRT into providing EGDT lead 
to a decrease in overall resource utilization.  Benson, et al (2014) and Sebat, et al (2007) 
both showed a trend towards a decrease in ICU utilization, although Sebat, et al (2007) 
also showed a trend toward longer overall hospitalization stays.  Umscheid, et al 
(2015)did not find an impact on ICU utilization.  Zubrow, et al (2008) is the only study 
that found a significant decrease in hospital LOS by 34%. 
Disposition: 
 Very few studies reviewed the impact on RRT involvement in post-discharge 
disposition beyond that of mortality.  Umscheid, et al (2015) found a trend towards an 
increase in discharges to home.  Sebat, et al (2005) did find a significantly increased 
likelihood of discharge to home with Zubrow, et al (2008) showing a 188.2% increase in 
home discharges in patients that had a RRT based intervention.   
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EGDT implementation and timing:   
Only two studies analyzed if the action of initiating a screening process so as to 
trigger an RRT would have an impact on earlier sepsis detection.  Linehop, Kaplan, and 
Gray (2008) and Umscheid, et al (2015) both showed that there was an increase in sepsis 
detection through the implementation of a standardized sepsis screening process for staff 
nurses.  
  For the majority of the studies that assessed RRT impact on EGDT 
implementation, they showed a statistically significant improvement in some if not all 
EGDT therapy components.  Miano, et al (2012) found that a protocol for antibiotic 
administration provided a 32% increase in appropriate bacterial coverage over provider 
preference.  Sarani, Brenner, Gabel, Myers, Gibson, and Fuchs (2008) showed that a 
RRT decreased the average time to administration of antibiotics by 102 minutes, 
mirroring the finding of Blumstein and Jones (2013) which showed a 60% increase in 
antibiotic administration compliance.  Sebat, et al (2005) showed a trend towards 
improvement in antibiotic administration times but did find a 50% improvement in 
intravenous fluid administration times. 
Umscheid, et al (2015), Zubrow, et al (2008), and Sebat, et al (2007) all found 
that a rapid response system for sepsis lead to a decrease in EGDT implementation times 
and an increase in compliance with all EGDT components.   Benson, et al (2014) also 
found an increase in all EGDT components, but did not analyze implementation times.  
These results are countered by the work of Berg, Vasquez, Hale, Nyberg, and Moran 
(2011) which showed that implementing a RRT specifically to identify and treat sepsis 
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with EGDT did not lead to an significant differences in compliance rates.  Berg, et al 
(2011) did find that the root causes of compliance failure was significantly different, with 
the RRT being more likely to implement therapy then in standard care, but failing to 
complete it within the prescribed time period.     
Table 3- Summation of Evidence 
Article Findings 
Benson (2014) -No change in mortality. 
 
- Significant increase in compliance with EGDT. 
 
-Trend towards decreased ICU use. 
Berg (2011) -No difference between RRT and standard of care in  
 
EGDT implementation 
Blumstein (2013) -Decreased mortality  
 
-A 60% decrease in time-to-treat with 1st antibiotic 
Lienhop (2008) -Sepsis screening associated with a reduction in  
 
Mortality 
Sarani (2008) -Antibiotics were administered 3 times faster  
Sebat (2005) -Decrease in time-to-treat with IV fluids, transfer time  
 
to ICU, and likelihood of discharge to home 
 
-Trend to decreased mortality and decreased time-to- 
 
treat with 1st antibiotic 
Sebat (2007) -decreased time-to-treat with all EGDT 
 
-decreased mortality by 18.6% 
 
-showed association between EGDT compliance and  
 
mortality 
 
-number needed to treat (NNT) to avoid a negative  
 
patient outcome was 3 
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-trend towards decreased ICU utilization 
Umscheid (2015) -Increased early identification of sepsis 
 
- increased compliance and time to complete with all  
 
EGDT therapies 
 
-Trend towards decreased mortality and increased  
 
discharge to home 
Zubrow (2008) -Decreased mortality by 49.4% 
 
-Decreased LOS by 34% 
 
- Increased discharges to home by 188% 
 
Limitations and Gaps in the Literature: 
 One of the largest gaps in the literature is that there is a dearth of high-grade 
evidence specifically relating to RRTs and their treatment of sepsis syndromes.  By their 
design, RRTs are intended to respond to a wide variety of critical situations, and so most 
studies focused on outcomes of RRTs are dealing with a population with a wide variety 
of medical issues.  The nature of a RRT incident does not lend itself to being able to 
perform a blinded randomized control trial.  There is a rather extensive body of 
knowledge focused on RRTs and their impact on hospitalized patients, but little evidence 
specifically detailing their interaction with septic patients and their ability to 
appropriately treat these patients.     
 Of the articles reviewed, there were nine that specifically evaluated the 
compliance of EGDT, either as a whole or by the individual components.  Several articles 
looked specifically at compliance (Benson, 2014; Miano, 2012), while others focused on 
intervention time (Sebat, 2005; Sarani, 2008; Sebat, 2007) or both (Berg, 2011; Zubrow, 
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2008; Umscheid, 2015).  The impact of increased compliance and decreased intervention 
time in this review of literature has shown either associated improvement in outcomes 
(Sebat, 2005; Sebat, 2007; Zubrow, 2008) or no significant impact on outcomes (Benson, 
2014, Umscheid, 2015).  The results of Benson, et al (2014) and Umscheid (2015) are in 
contrast to the preponderance of sepsis literature which has found a strong inverse 
association between increased compliance with EGDT and shortened intervention times 
and mortality in the rest of the sepsis literature (Dellinger, 2013; Kumar, 2006).   
 There were some inconsistencies with the broader sepsis literature.  Of the nine 
articles in this review, only three (Sebat, 2005; Sebat, 2007; Zubrow, 2008) showed the 
beneficial impact of effects of EGDT: a positive change in mortality, decreased LOS, and 
decreased ICU days.  Several of the articles were only intended to validate their specific 
intervention tool, and so focused more on proving the intervention could be done, not that 
it was effective or best practice.  Six of the ten (Blumstein, 2013; Linehop, 2008; Sebat, 
2005; Sebat, 2007; Umscheid, 2015; and Zubrow, 2008) measured  mortality as the 
primary outcome measurement, with three of those six also taking LOS into 
consideration, with only three differentiating between ICU LOS and total hospital LOS 
(Sebat, 2007).  The results of those three studies were inconsistent; Umscheid (2015) and 
Sebat (2007) found no change in hospital LOS, while Zubrow (2008) found a significant 
decrease in LOS.  With the conflicting results, there are still questions about the true 
impact of RRT initiated EGDT on hospital LOS, though its benefits to mortality well 
supported.  Sebat, et al (2005) and Zubrow, et al (2008) were the only studies that 
analyzed discharge destination, though their results concurred that there was a greater 
propensity for discharge to home or to a rehab facility then a nursing home.  None of the 
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articles reviewed addressed the positive impact the intervention could have on reducing 
cost-of-care that has been shown in the wider sepsis literature (Shorr, et al., 2007 and 
Teres, et al, 2002). 
 One challenge associated with testing the impact of interventions performed by an 
RRT is that there is variation in criteria for initiating the rapid response system.  SIRS 
criteria are part of the defining characteristics of sepsis (Bone, 1992), but it was not used 
exclusively as the triggering criteria in all studies.  Meeting SIRS criteria was cited as 
being the trigger for a rapid response call in six of the ten studies cited (Benson, 2014; 
Blumstein, 2013; Linehop, 2008; Sebat, et al, 2005; Sebat, et al, 2007; Umscheid, et al, 
2015), with half of those having an additional qualifier, such as anion gap acidosis 
(Benson, 2014) and hypotension (Sebat, 2005; Umscheid, 2015).  Different triggering 
criteria for RRT initiation means that you may be comparing studies that may have a 
different triggering situation: sepsis versus severe sepsis versus septic shock.   
Discussion: 
Based on this review of evidence, use of a rapid response system for prompt 
initiation of EGDT in non-critical-care areas of the hospital should improve patient 
outcomes.  Patients in these areas could face treatment delays due to staff unfamiliarity 
with EGDT protocol, as well as logistic delays due to unit staffing, unavailable resources, 
and therapy delayed while transferring the patient to a critical-care area.  
A benefit to utilizing an RRT as a means of delivery of EGDT to patients 
identified as septic on the hospital wards is that it is easier to focus therapy education to a 
select few who can then have a hospital-wide impact.  Jaderling, et al. (2013) found that 
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critical-care trained nurses on an RRT can be more effective at identifying severe sepsis 
and the requisite need for transferring the patient to a higher level of care.  While sepsis 
identification can be made just as well by the primary medical team if they personally 
assess the patient (Quach, 2008), the consistent availability and level of expertise that a 
well-trained RRT provides would allow for continuity of care. 
Based on the review of these nine studies, RRTs appear to be an effective method 
of delivering EGDT to septic patients in non-critical areas.  These studies suggest that, 
regardless of team composition, by empowering and educating the RRT to identify sepsis 
and initiate the appropriate EGDT, they can improve the accuracy of EGDT and the 
efficacy with which it is initiated.  Sebat, et al (2005; 2007) and Zubrow, et al (2008) 
consistently found that these improvements in decreased initiation time and increased 
compliance were associated with a decrease in mortality, ICU usage, and either a 
decrease in LOS, or at worse no change.  RRT EGDT was found in several articles to 
lead to an increase in likelihood of the patient being discharged to home (Zubrow, 2008; 
Sebat, 2005; Umscheid, 2015), an improvement in patient quality of life on discharge 
(Sebat, 2005; Zubrow, 2008), and a decrease in end-organ damage (Zubrow, 2008).   
It is unclear as to what is the optimal composition of a rapid response team.  A 
team that included an APP would have the benefit of having a member who could order 
additional therapies and testing that may not be covered by existing protocols.  A noted 
flaw of most of the non-APP RRTs is that they did not have the ability to provide one of 
the most crucial aspects of EGDT, the antibiotics.  A counter strategy for addressing this 
gap would be by empowering your RRT to order patient-specific antibiotics based off an 
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algorithm reflecting local antibiograms, resistance patterns, and hospital formulary 
(Miano, 2012).   
Another aspect of logistics to consider is the criteria required to trigger a rapid 
response system.  Throughout the literature, there were varying triggers utilized for rapid 
response system initiation, from SIRS criteria (Funk, Sebat, & Kumar, 2009) to specific 
abnormalities such as hypotension (Sebat, et al. 2007).  While a focus on a specific 
trigger criterion, such as hypotension, will increase the specificity of the screening 
process, it will lead to a subsequent decrease in sensitivity that could delay identification 
and intervention and potentially result in a worse outcome for the patient.  A concern is 
that, by treating patients who are not septic as if they were, you are overusing resources.  
This is countered by Sebat, et al (2007), who showed that the number needed to treat 
(NNT) to avoid a negative outcome was 3, a far lower NNT for other critical illnesses 
such as stroke or myocardial infarction.  In fact, Funk, Sebat, & Kumar (2009) suggest 
that simply focusing on the SIRS criteria as a trigger is insufficient and utilized a broader 
set of criteria.  It is uncertain if using additional criteria, and the requisite testing to 
acquire the data, provides a significant improvement to care to offset any negative 
iatrogenic consequences.  Having a higher threshold for triggering an RRT could 
potentially lead to a delay in treatment, which has been shown to be associated with a 
three-fold increase in mortality in decompensating patients (Quach, 2008).  Most of the 
literature reviewed utilized the starting point of severe sepsis, which seems a reasonable 
compromise; the patients will have identifiable abnormalities that can increase specificity 
of treatment while hopefully being caught early enough so as to avoid the progression to 
irreversible septic shock.       
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 In closing, this paper reviewed the literature to determine if it would be beneficial 
and feasible to utilize an RRT as a conduit for EGDT in non-critical care areas.  The 
review found that, regardless of the team member composition, an RRT was able to 
provide EGDT to identified septic patients more efficiently, which was associated with a 
decrease in mortality, ICU usage and LOS, and a reduction in hospital LOS.  These 
patients appeared to have lower rates of morbidity, fewer cases of end-organ 
insufficiency, a higher quality of life and more frequent discharges to home or rehab 
versus a skilled nursing facility.  An RRT that included an APP such as a physician or NP 
could initiate antibiotics immediately, but other options existed such as a pre-determined 
patient-specific antibiotic algorithm for use.  In fact, broader and more appropriate 
antibiotic coverage may be obtainable with a protocol-driven antibiotic prescription then 
is potentially prescribed by individual provider preference (Miano, 2012).  It is 
imperative that organizational logistics such as hospital wide screening education and 
tools be developed and in place to promote triggering the RRT as soon as a case of sepsis 
can be identified in a non-critical area.  It is also crucial that, after the RRT has identified 
a need of a stabilization effort for the patient, that there are organizational processes to 
provide the team with requisite medications, equipment, and transfer to a critical care 
area in as efficient a manner as possible without causing further delays in therapy.  
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Background: 
 There is a growing demand for critical care services in the United States that has 
outpaced the supply of physicians with Intensivist training (US Department of Health and 
Human Services, 2006).  This has led to a growing number of Acute Care Nurse 
Practitioners (ACNP) filling roles that were traditionally the purview of our physician 
colleagues (Howie-Esquivel, J. & Fontaine, D. K. 2006).  Given that, in the United 
States, 15.6% of all deaths occur in the intensive care unit (ICU) (The Dartmouth Atlas 
for Health Care, 2012), ACNPs are increasingly being called upon to initiate and address 
end of life (EOL) issues and concerns.  This paper will explore issues and provide 
recommendations for aiding the ACNP to negotiate the delicate process of supporting 
inpatients and their families dealing with this tumultuous time.    
How Americans Die: 
The primary goal of critical care medicine is to support patients in recovering 
from life-threatening illness while maximizing their quality of life and return to 
functionality.  This goal is not achieved without sacrifice as critical care medicine entails 
aggressive, sometimes painful, therapies that are nevertheless requisite to provide the 
patient the greatest chance of recovery.  Eventually though, recovery is not a viable 
option, and one in five Americans dies in the ICU after long, and sometimes futile, efforts 
(Angus, et al., 2004).  This issue was first addressed in 1995 in the SUPPORT study, a 
multimillion dollar, multisite, randomized control trial that found a lack of awareness on 
the part of providers as to patient wishes and a high rate of patient deaths in “undesirable 
states” of pain and suffering.  Despite awareness of the issue, our healthcare system 
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continues to inadequately provide for the needs of this vulnerable population, leading to 
higher dissatisfaction scores with care for patients and their families, increased use of 
emergency services, poor symptom and pain management, and institutionalized death as 
opposed to home-based dying (Aziz, Miller, & Curtis, 2012; Giovanni, 2012).   
It is reasonable to understand why patients, when faced with the realistic 
possibility of death, would choose not to go gently into that good night.  The desire to 
survive is inherent in all creatures and there is difficulty in providing patients with 
specific and exact prognostication as to if or when death will come or if the patient will 
be left with profound debilitation (Barnato, Albert, Angus, Lave, & Degenholtz, 2011).  
These two truths are why many patients, who may have professed a desire for a quiet and 
dignified death, are willing to pay a high price to maintain the struggle.  This bears out 
the dissonance noted between people’s expressed desire to die at home versus the actual 
state of things.  While 7 out of 10 Americans express a desire to die at home (Pew 
Research Center, 2006) only 27% do so (CDC, 2013).  
This natural unwillingness to confront an unpleasant truth of life, that we are 
mortal, lends itself to patients avoiding making advance directives to guide their EOL 
care.  A recent report by the Institute of Medicine (2014) found that only 47% of 
Americans over the age of 40 had an advance directive (AD), although this percentage 
was higher in hospice patients (88%) and those who resided in a nursing home (66%).  
This unwillingness is also reflected in healthcare professionals who can be uncomfortable 
discussing poor prognoses, patient values, or treatment preferences in a terminal setting 
(Scheunemann, Cunningham, Arnold, Buddadhumaruk, & White, 2015).  This 
unwillingness may stem in part as physicians often feel there just is not enough time to 
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discuss EOL issues adequately with patients (Tunzi, M., 2011), letting these discussions 
fall on other staff members (nurses, social workers, chaplains), which then leads to 
elevated distress and confusion for staff and patients (Burgess, Cha, & Tung., 2011).   
End of Life (EOL) Decision Making: 
End of Life (EOL) decision making is the process whereby patients, their 
families, and healthcare providers address what therapies and procedures are to be 
utilized when facing a life-threatening disease process.  With the exception of advance 
directives, most EOL decision-making occurs as the patient approaches death (Teno, 
Lynn, Wenger, Phillips, Murphy, and Knaus, et al.  1997).  EOL decisions can be viewed 
as addressing three key components; the limitation of additional care, the removal of 
existing care, and transitioning from curative care to comfort care.   
Limitation of care establishes what therapies the patient would or would not want, 
such as hemodialysis or mechanical ventilation and, if they are desired, for how long of a 
period.  Limitation of care does not preclude the pursuit of curative care, but rather, 
simply places boundaries on how far that pursuit is to be taken.   
Removal of care focuses on reducing therapies that no longer provide a sufficient 
benefit-cost ratio.  This may entail the removal of uncomfortable therapies such as tubes 
or the discontinuation of medications that, while not causing discomfort, are not 
promoting wellness, only prolonging the dying process.     
Finally, “comfort care” is composed only of therapies that are meant to alleviate 
the symptomology of the dying process.  The focus of these therapies is not to hasten 
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death, though that may be a foreseeable side effect, but rather to ensure that the patient is 
not in distress in their final moments.   
 These three components of EOL care are not mutually exclusive and individual 
patients will have varying levels of each based on clinical presentation and patient/family 
comfort.  It is not uncommon for individuals to be unwilling to discontinue one life-
prolonging therapy, such as mechanical ventilation, while stopping medications that are 
just as life-prolonging.  Other clinical issues such as the use of paralytics and an intention 
for organ donation can impact what therapies the patient may receive towards the end of 
their life. 
End of Life (EOL) Decision making:  
Ideally, long before the patient is being faced with a life-threatening crisis, there 
has been a conversation between the patient, their medical provider, and their family 
which resulted in clear guidelines for going forward.  One form of those guidelines is 
called an Advanced Medical Directive or “living will,” a document that expresses what 
everyone agrees is the patient’s goals for care.  An Advanced Medical Directive does not 
necessarily limit the provision of care, merely clarifies the patient’s wishes in event that 
they are not able to express them.  A similar document that is not as extensive is a Do Not 
Resuscitate/Do Not Intubate (DNR/DNI) order, which does limit the patient’s care in 
accordance with the patient’s wishes in the event of a cardiac/pulmonary arrest, but does 
not limit the care preceding such an event.  Neither of these documents precludes the 
other.  Unfortunately, these documents are often too static and generic to address every 
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possible scenario of EOL care and so it is preferable that there be a person who can 
accurately represent the wishes of the patient when they are no longer able. 
Patients are often not capable of being involved in their own EOL decisions 
whether due to illness or medications (Baggs and Schmitt, 2000).  For this reason the 
patient should specify someone as their “medical decision surrogate.”  Commonly, this 
person is their spouse or their next of kin who is legally allowed to make medical 
decisions, although that need not necessarily be so.  It is possible to elect someone as 
your durable power of attorney (POA) for all medical decisions, though this does require 
some provenance of documentation.  Failing a previous designation of a POA, then 
medical decision making capacity passes to the next person legally empowered to make 
decisions for the patient; their spouse, their adult children, their parents, their extended 
family members in descending order, though this chain of empowerment can vary 
according to state law.     
Research has shown that, traditionally, family members move along a continuum 
when making EOL decisions (Tilden, Tolle, Nelson, Thompson, & Eggman, 1999; 
Swigart, Lidz, Butterworth, & Arnold, 1996).  As the patient fails to improve, the 
surrogate will gather information related to potential outcomes and prognosis.  When the 
reality that their loved one will not improve crystalizes for them, they then begin to 
imagine what that person would want, based off of expressed intent or known values.  
Once they have an impression of what the patient would want, they next need to develop 
comfort with the role and responsibility of acting as the surrogate and what impact that 
will have on themselves and the extended family dynamic.  When they are at this point, 
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they are fully capable of acting as the patient’s healthcare surrogate.     Unfortunately, 
research shows that this ideal situation is often far from reality.   
Less than half of all patients have advance directives (IOM, 2014), and those that 
do were followed only 50% of the time due to dissonance between the patient’s stated 
wishes and the wishes of their next of kin or the medical team (Teno, Licks, Lynn, 
Wenger, Connors, and Knaus, et al., 1997) as relates to EOL care.  Additionally, there is 
the risk that members of the medical team may supplant the wishes of patients and their 
designated surrogates for their own judgement of what EOL care should entail (Cassel, 
Buchman, Streat, & Stewart, 2003) either because of thoughts of superior knowledge, 
misunderstanding of the viewpoint of the layperson, personal viewpoints, or as a 
misguided attempt to alleviate guilt for the surrogate.  Sometimes, the issue is simply that 
there is not a copy of the AD available to the medical team at the moment of crisis 
(Guiterrez, 2012).  When a decision finally is reached to proceed with comfort care 
measures, on average this occurs 2 days prior to death, suggesting an avoidable delay in 
appropriate EOL care (Teno, Licks, Lynn, Wenger, Connors, and Knaus, et al., 1997). 
The State of NP Preparation to provide End-of-Life Care:  
There is a lack of knowledge and undergraduate didactic preparation for nurses 
related to end-of-life care (Shea, Grossman, Wallace, & Lange, 2010; Iglesias, Pascual, 
Vallejo, 2013).  The Institute of Medicine recommended as far back as 1997 that end-of-
life care be incorporated into nurse practitioner education and that specially prepared 
programs be available for interested practitioners.  Given the limited preparation 
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undergraduate nurses receive, it is vital that advance practice nurses gain knowledge and 
confidence on caring for this patient population.  
The End-of-life Nursing Education Consortium (ELNEC) program that was 
created by the Robert Wood Johnson Foundation as a means to educate nurse 
practitioners on how to provide appropriate end-of-life care (Grant, Wiencek, Virani, 
Uman, Munevar, & Ferrell, 2013).  Shea and colleagues (2010) found that, though APRN 
students did not start out with a strong understanding of palliative care principles prior to 
receiving ELNEC training, they afterwards recognized the necessity of EOL education, 
expressed a desire to gain that understanding, and felt that incorporating ELNEC modules 
into graduate level education would be a benefit.   
Patient Experiences: 
An ICU is not a peaceful place by nature, and so it may not provide the best venue 
for patients undergoing the dying process.  Spiritual care is infrequently provided in 
intensive care for patients receiving EOL care despite stated patient preferences (Balboni, 
Sullivan, Amobi, Phelps, Gorman, & Balboni, et al., 2013).  Balboni, et al. (2013) found 
that, while the nurses and physicians they studied felt that providing spiritual care was 
important and appropriate, they did not have adequate training to do so.  Patients 
undergoing the end-of-life stages of their medical illnesses are more vulnerable than other 
patients dealing with those same illnesses as they are more prone to higher levels of pain 
and anxiety (Denny & Guido, 2012; Wilkie & Ezenwa, 2012).  While experiencing 
higher levels of pain and or anxiety, these patients will often have limitations in their 
ability to clearly express these sensations to others due to the severity of their illness.   
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Family Impact: 
Families do not exist in a vacuum, nor does the impact of their decisions cease 
with the death of their loved one.  Tilden, et al (1999) found high levels of stress in 
family members 1 and 6 months after withdrawal of care. The authors also found high 
levels of guilt being reported due to selfish delays in decision making.  Norton and 
Bowers (2000) reported that some family members found the impact of making these 
decisions “devastating,” while others were proud they were able to honor the wishes of 
their loved one.  A literature review by Gardiner and associates (2014) found that the 
economic impact on families to be poorly researched, but likely to be significant.    
Impact on Staff: 
End-of-life decision making has been identified as the most common ethical 
dilemma for both nurses and physicians (Oberle, & Hughes, 2001).  Oberle and Hughes 
(2001) found that physicians often felt responsible considering they were the ones writing 
the palliative orders.  Involvement in end-of-life care has been shown to be a source for 
moral distress amongst critical care nurses (American Association of Critical-Care 
Nurses, 2012), most commonly due to nurses providing what they feel as being futile care 
(Meltzer & Muckabay, 2007).  This distress has been shown to be negatively correlated 
with the nurses’ level of collaboration in discussing therapy and end-of-life-care 
education.  By empowering staff to feel involved and seeking their collaboration in 
decision-making, there is a reduction in the frequency of moral distress (Browning, 
2013).  This involvement and empowerment is crucial, as the nursing staff are the 
healthcare members most likely to have built a relationship with the patient and their 
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family.  Staff who work in critical care areas are traditionally focused on curing disease 
and prolonging life, so there may be distress when moving to a palliative model of care.   
Resource Utilization: 
There is no fiscally responsible reasoning behind providing expensive, yet 
useless, intensive care to patients in terminal illness, yet that is the fate for 1 in 5 of 
Americans.  Forty percent of Medicare decedents are admitted to the ICU during their 
terminal illness and 25% of all Medicare spending is in the last year of life due to the 
high cost of intensive care (Marik, 2006; Hupcey, Penrod, & Fogg, 2009).  Patients who 
die in the hospital have overall higher length-of-stay (12.9 days vs. 8.9 days) and cost-of-
care ($24,541 vs. $8,548) than non-ICU terminal hospitalizations (Angus, Barnato, 
Linde-Zwirble, Weissfeld, Watson, & Rubenfeld, et al. 2004) and a higher overall cost 
than ICU survivors (Scitovsky, 2005).  This higher cost of care does not appear to relate 
to having a higher quality of death (Khandewal, Engelberg, Benkeser, Coe, & Curtis, 
2014).  A possible reason for this was shown in a study by Khandewal, et al (2014) that 
found a positive correlation between family-satisfaction with care and quality of death 
and healthcare expenditures in patients that were underinsured; this creates a toxic 
environment where families expect expensive therapies that the hospital will not be 
reimbursed for and that will invariably not translate to any actual impact for the patient.       
Ethical/Legal Concerns:  
A series of legal decisions have concluded that it is legal and justified for a 
competent person to refuse, at any point, any medical therapy, whether it is life-
sustaining or not (McGowan, 2011).  This right is limited only in prevention of suicide 
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and in protection of third parties (such as children).  If a person becomes incompetent 
through either debility or disease, but had a previously detailed advance directive, then 
that advance directive is to be carried out on the patient’s behalf.  These can be difficult 
situations where there is disagreement as to  a patient’s competency and such 
determination would need to be reached by a judge, although this is rarely the case in 
end-of-life situations.       
As previously stated, if the patient becomes unable to make their own decisions, a 
surrogate decision maker must be identified.  If the patient had previously identified 
someone in their advance directives, then they have ultimate authority.  Failing a prior 
designation, then authority passes to a relative.  The exact order varies by state, but 
commonly it is (in descending priority); spouse, adult child, parents, adult sibling, and 
finally other adult relatives.   
End-of-life decision making processes usually follow the ethical principles of 
autonomy and beneficence.  These ethical principles are represented in the “substituted 
judgement standard” and the “best interest standard.”  The “substituted judgement 
standard” means that the surrogate is asked to take what they know of the patient’s values 
and previous statements and attempt to determine what they would have wanted in the 
situation.  The “best interest standard” means that the surrogate assesses the benefit/risk 
ratio for therapy to the patient and selects those therapies for which the benefit outweighs 
the burden of care.  In this standard, there is an additional aspect of objectivity as the 
decision is based off of known success and failure rates of therapies, though there is the 
risk of supplanting the patient’s perceived autonomous values with those of the surrogate.  
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When treatment carries no appreciable benefit to the patient, it is considered to be 
medically futile.  Futility of care carries significant personnel and cost of care 
ramifications, which have been discussed previously (Gardiner, et al., 2013; AACN 
2012).  Conflict between the healthcare team and families about providing medically 
futile care are uncommon, but can occur.  Ideally, this conflict can be resolved without 
legal intervention, either through improving communication or developing joint decision 
making so as to resolve disputes.  If the dispute cannot be resolved, then it is advisable to 
involve an interested third party, such as the institution’s ethics board, for a review.  This 
review can help determine if the care of the patient needs to be transferred to another 
medical provider so as to receive treatment or, in the case where treatment is deemed 
futile, if transfer to another institution can be obtained.  Failing the ability to transfer the 
patient to another facility however, the intervention need not be offered.  It should be 
noted that prior to such extreme measures all opportunities should be taken to achieve a 
harmonious resolution so as to avoid distress for the patient, their family, and the staff.   
The utilization of sedatives and opioids to relieve suffering regardless of their 
potential impact on hastening death is warranted under the concept of “double effect” 
(Denny & Guido, 2012).  As Denny and Guido discuss, so long as the intent of the 
healthcare provider is to provide adequate medications for comfort, it is legally and 
ethically sound to provide these, even knowing they may have an undesired impact on 
vital function as confirmed by the Supreme Court ruling of Cruzan v. Director, Missouri 
Department of Health (McGowan, 2011).  The provider needs to be cautious about how 
ordering such therapy could be perceived by staff and family members.  The limitations 
on NP prescribing opioids and anxiolytics are often not an issue with in-patient 
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populations, so long as the provider’s state and institution do not limit the prescriptive 
authority of the NP.   
Recommendations and Strategies: 
Socioeconomic forces are driving a greater and greater need for critical care 
services, while limiting traditional care delivery models.  This is leading to the increasing 
utilization of Nurse Practitioners (NP) as active members in the multidisciplinary team 
that determines the medical treatment course of critically ill patients.  Undergraduate 
nursing education lacks the didactic preparation to prepare nurses for adequate EOL care 
(Grant, et al, 2013; Denny and Guido, 2012) and graduate level programs have not 
moved to address this educational gap (Lu, et al., 2015).  For these reasons, this paper 
offers some useful, evidence based recommendations for how to approach patients and 
their families when having EOL conversations and shepherding them through EOL care.     
Communication:  
Throughout the research, clear and open communication has been repeatedly 
reported as being one of the most crucial strategies for aiding patients and their families.  
Communicating with families can improve their satisfaction with EOL care, but only if it 
is done in such a manner that does not make them feel hurried to make EOL decisions 
(Jacobski, Girard, Mulder, & Wesley, 2010).  It is important to bear in mind that 
communication is more than just the spoken word; providing time and space for 
processing and accepting the information provided has been shown to be of benefit to 
patient’s families when receiving news of a terminal illness (Tilden, et al, 1999).  Tilden 
and associates (1999) also reported that family members found it beneficial when the 
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provider “stop[ped] and listen[ed]” to their concerns, questions, and fears. It is easier for 
families to be given the facts, recommendations, and then make a decision as a group 
rather than just being provided with facts and no context or guidance (Tilden, et al, 1999).   
It is vital that the NP at all times communicate in an open and honest method with 
the patient and their family.  The same can be said for when the NP is discussing the plan 
of care with the multidisciplinary team, as miscommunication of the plan or 
misunderstanding of the purpose of some therapies has been shown to lead to moral 
distress for some of the staff.  Scheunemann and associates (2015) provide some 
guidelines for how to effectively communicate about EOL care:  
1.  Identify key stakeholders (patient, surrogate, spouse, etc.)  
2. Coordinate a period of time when no one will be rushed in a quiet personal space. 
3. Assess the current level of understanding. 
4. Determine willingness to hear information. 
5. Deliver medical information 
a. Communicate in a clear method without utilizing euphemisms or vague 
statements about clinical presentation or disease trajectory. 
6. Acknowledge and address emotional response 
7. Establish goals of care for all potential realistic clinical scenarios 
a. Anticipate potential clinical scenarios and discuss with the patient and family 
b. Proactively address reasonable fears of discomfort (such as dyspnea) and 
present a plan for dealing with it (narcotics/sedatives). 
8.  Follow up with family and patient on a regular basis and apprise them of clinical 
changes that are portentous for death.   
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Do not present care options as being a choice between aggressive versus comfort, 
as this can leave family members as feeling abandoned and forced into deciding whether 
or not to “give up.”  When presenting treatment options, providers should be aware of 
their phrasing so as to present them as “value-neutral” (Lu, Mohan, Alexander, Mescher, 
Barnato, 2015).  Here are some examples of how commonly said phrases could have a 
more tactful and productive impact. 
Working the Process: 
 Discussing and planning for EOL care should be undertaken in a multidisciplinary 
manner which includes the patient as an equal stakeholder.  If, as is often the case in EOL 
scenarios, the patient is not able to speak for themselves, then a specific and legal 
surrogate must be identified and included.  It is vital that this surrogate be respected as an 
equal partner, as they represent the patient’s preferences and wishes.  Multidisciplinary 
rounding and involvement in family meetings helps foster improved communication and 
understanding, providing clarity for all stakeholders in EOL decision making (Delgado, 
Callahan, Paganelli, Reville, Parks, & Marik, 2009).   
Group decisions lead to a more satisfactory viewpoint for all team members and 
help to ensure that the plan is one that focuses on the patient and their autonomous needs 
and wishes, not those of any other involved individual.  Specialist consultation with a 
Palliative Care Service (PCS) should be sought in order to provide expertise to the 
conversation on symptom management as well as emotional and spiritual support for the 
patient and their family.  An additional benefit of a PCS consultation is that if there is an 
actual or perceived “lack of time” on the part of the primary providers to fully explore 
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and address EOL issues, this service can aid in the discussion.  A lack of time does not 
justify impinging on patient autonomy or delaying desired palliation of symptoms at 
EOL.    
Meet after 48 hours to discuss GOC in patients with high risk of dying (Seaman, 
2013).  These family meetings should be continued every couple of days to keep the 
family members current on clinical changes the healthcare team are seeing.  A reasonable 
place to start in the absence of advance directives is to first determine what to do in the 
event of a cardiopulmonary arrest.  Resuscitative measures in dying patients are not 
health-promoting, but rather death-prolonging and carry with them significant negative 
effects such as pain, suffering, and additional medical intervention.  After a decision has 
been reached on code status, the provider can explore with the patient/surrogate other 
limitations of care that are consistent with that patient’s values.  All therapies should be 
detailed as to their benefit/risk ratio and the patient should be given the option whether a 
therapy is desired or not.   It is perfectly reasonable to attempt a “trial of aggressive care,” 
including intubation if need be, to provide the maximum opportunity for patient 
improvement, but clear cut off points need to be agreed upon for when therapy is no 
longer health-promoting, but rather death-prolonging. 
Norton and Bowers (2001) developed a stepwise approach for healthcare 
providers to support the family in transitioning from a curative to a palliative approach.  
These steps provide a framework by which the medical providers can begin the process 
of identifying what are the desires and goals of the patient and potentially addressing the 
need of limiting futile efforts at the end of life.  
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1. Develop trust 
2. Provide information 
3. “Plant seeds” about prognosis 
4. Provide consistent perspective from all healthcare members 
5. Hold meetings with family 
6. Involve ancillary disciplines/services (social services, chaplain, PCS) 
7. Continue to support decisions 
8. Reiterate information as needed 
9. Redirect hope from cure to comfort 
 
Table 4 - Communication Strategies 
Instead of….. Say…… 
Do you want us to intubate your family 
member? 
-Did they ever express to you any thoughts  
 
on using life support at the end of life? 
 
-We are concerned that a ventilator will  
 
only prolong the dying process. 
 
- There is a strong possibility that they will  
 
die attached to this machine 
 
- As an alternative plan, we can refocus our  
 
care towards maximizing their comfort and  
 
treat any distressing symptoms with  
 
medications 
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Do you want us to resuscitate your family  
 
member? 
 
Are they a full code? 
-Your family member is dying, and we  
 
anticipate that their heart will stop soon. 
 
-Given their severe illness, it is unlikely  
 
that an attempt at resuscitation would be  
 
successful; if it was successful, most likely  
 
that they would have significant  
 
impairment, if they even survived. 
 
-We are only discussing what to do in the  
 
event of their heart stopping.  This does not  
 
mean that we will not do all that we can for  
 
them prior to that event. 
Let’s just…. -Based on what I’m hearing from you, I  
 
recommend that we…. 
 
-We will aggressively manage their  
 
symptoms within the guidelines that they  
 
have established with their wishes. 
 
-We will use all our resources to support  
 
them up until the point where their heart  
 
stops or they stop breathing.  If that were to  
 
happen, we will allow them to have a  
 
natural, peaceful death 
 
-We will not needlessly prolong the dying  
 
process. 
   
 72 
Specific Interventions for End-of-Life Care: 
It is crucial that the nurse practitioner be able to address common problems in the 
dying patient: secretions, dyspnea, pain, delirium, fatigue, loss of sphincter control, 
nutrition/hydration, and avoidance of dry eyes/mucous membranes.  Providers will need 
to be comfortable prescribing scheduled comfort medications (preferably PO) with IV for 
breakthrough.  If IV access is difficult to obtain, keep in mind that many comfort 
medications could be given through a SC route.  A full discussion on EOL pharmacology 
is outside of the scope of this paper, but there are evidence-based online resources 
available such as ELNEC or UpToDate.com (Bailey & Harman, 2015).    
Bailey and Harman (2015) advise judicious utilization of narcotics to manage the 
primary symptoms of end-of-life; dyspnea and pain.  They recommend providers be 
aggressive in managing symptoms, but remember that the goal is comfort.  Most patients 
and their families would prefer they be cognizant and able to interact for as long as is 
comfortably possible.  It is appropriate to start off with PRN medications with a plan for 
escalation of medication dosage and scheduling if needed.  If patients are requiring 
frequent dosing, then a continuous infusion may provide more comfort.  Discontinue 
unneeded medications, excepting cardiac meds and meds that act on the central nervous 
system as their abrupt removal could potentiate seizures.  There is no evidence to support 
oxygen therapy for comfort except as  incurring a placebo effect.  Intravenous hydration 
can prolong the dying process needlessly; it is better to manage dry mucous membranes 
and dry eyes with oral hydration agents and eye drops respectively (Puntilo, Nelson, 
Weissman, Curtis, Weis, & Campbell, 2014).   
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If the patient is not likely to die within the next 12-24 hours, a decision should be 
made about the preferable location of death.  If they are stable enough, consider 
discharging the patient home with hospice.  If they are unlikely to survive such a transfer, 
but anticipated time of death is a matter of days, then a transfer to a private room on a 
designated palliative care floor is preferable if possible, so as to not needlessly tie up 
critical care resources and to provide the family a setting where there will be minimal 
intrusions.  If the patient is unlikely to survive long enough to allow for transfer out of the 
ICU, then all efforts should be taken to maximize family presence and visitation policies 
should be relaxed.   
Standardization of EOL care can help guide junior staff and support achievement 
of goals of care, but care must be taken to avoid depersonalizing the patient and their 
family.  Venkatasalu, Whiting, and Cairnduff (2015) described how an evidence-based 
care pathway called the Liverpool Care Pathway (LCP) provided guidance to staff and 
ensured standardization of quality of EOL care while the program was running.  
Unfortunately, public opinion and media criticism caused the program to be abandoned.  
This underlines the importance of recognizing the individuality of the patient and their 
family and managing the perception of care.  It is important that critical care providers 
encourage all patients, even those who have a low likelihood of death, to have EOL 
conversations with their loved one and physicians.    
Conclusion: 
As the population ages and we are able to prolong life, it is crucial that medical 
providers are able to help patients and their families navigate the balance between quality 
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and quantity of life. Specific communication strategies can help improve provider and 
patient understandings of available EOL care options and avoid unwarranted and 
potentially futile therapy.  Acute Care Nurse Practitioners (ACNP) are in a unique 
position to significantly contribute to the improvement of end-of-life care provided to 
patients in critical care areas.  As members of the multidisciplinary, ACNPs have a 
responsibility to help patients and their family best realize their care goals while 
enhancing their quality of life as much as possible.  When the moment of death is 
approaching, the ACNP will need to prepare the family so they know what to expect and 
to address their fears and expectations.   
In these emotionally charged moments, it is crucial that providers be aware of the 
ethical and legal guidelines that define decision making and that such decision making be 
undertaken in a multidisciplinary method that includes the patient or their surrogate as an 
equal partner. If there is a conflict between the viewpoint of the provider and the 
patient/surrogate, additional outside input from palliative care services or an ethics 
committee may help provide a way to move forward.   
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Capstone Conclusion: 
The journey towards achieving my Doctorate of Nursing Practice (DNP) has been 
a challenging one, but one well worth the effort.  I had already been prepared as a 
Masters of Science in Nursing to act as an Acute Care Nurse Practitioner in the care of 
my individual patients; now I am prepared not just to assess and intervene with individual 
patients, but systems and policies that can have an impact on countless more than I could 
ever conceivably help at the bedside.  The further academic empowerment that the DNP 
will provide allows me now to function on a higher level; one of policy development, 
program planning and evaluation, and as a leader on issues facing our profession.  I have 
gained a deeper knowledge and respect for the ability of policy change to initiate sizable 
impact, not just on the individual level, but on whole populations.  By achieving my DNP 
I can now speak as a peer in the discussions that occur at  levels away from the bedside 
that influence and shape our profession and the delivery of healthcare in this country.  It 
will allow me to further my own professional development, and thereby enhance my 
ability to foster the development of others in the nursing profession.  By obtaining my 
DNP, I now have an elevated vantage point to provide a clearer vision of the macrocosm 
of healthcare in America and been provided with the skillset to foster and actualize 
important improvements in how that healthcare is delivered on all levels.  I stand on the 
shoulders of the giants in the field that have come before me, ready to further the field 
and lift others up to even greater heights.   
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